Showing 5591-5600 of 5956 results for "".
- Novartis Announces FDA BLA Acceptance of Brolucizumab for Wet AMDhttps://modernod.com/news/novartis-announces-fda-filing-acceptance-and-priority-review-of-brolucizumab-for-wet-amd/2476468/Novartis announced that the FDA has accepted the company’s biologics license application (BLA) for brolucizumab (RTH258) for the treatment of wet age-related macular degeneration (AMD). Novartis used a priority review voucher to expedite FDA review and anticipates launching brolucizumab, if
- Alimera Sciences Appoints Samer Kaba, MD, as Chief Medical Officerhttps://modernod.com/news/alimera-sciences-appoints-samer-kaba-md-as-chief-medical-officer/2476464/Alimera Sciences announced an expansion of its leadership team with the appointment of Samer Kaba, MD, as Chief Medical Officer, effective April 4, 2019. “I am very pleased that Samer will be joining us in this new position as he will bring both a physician’s perspect
- US Ophthalmologists Push to Remove Roadblocks to Patients’ Access to Medical and Surgical Eye Carehttps://modernod.com/news/us-ophthalmologists-push-to-remove-roadblocks-to-patients-access-to-medical-and-surgical-eye-care/2476461/More than 400 eye physicians and surgeons from across the United States are in Washington, DC, to urge Congress to end federal policies that delay patients’ access to quality medical and surgical eye care. As part of its annual visit to Capitol Hill, the American Academy of Ophthalmology (AAO) is
- Texas Tech Medical School to End Use of Race in Admissionshttps://modernod.com/news/texas-tech-medical-school-to-end-use-of-race-in-admissions/2476462/Texas Tech University’s medical school has agreed to end its consideration of race in selecting candidates for admission, an outcome actively sought by the Trump administration. The Texas Tech University Health Sciences Center submitted to pressure from the Education Department’s Offi
- I-MED Pharma Becomes Authorized Canadian Distributor for OrCam MyEye 2https://modernod.com/news/i-med-pharma-becomes-authorized-canadian-distributor-for-orcam-myeye-2/2476463/I-MED Pharma, a Canadian company specializing in dry eye diagnosis and management, announced the signing of an authorized Canadian distribution agreement with OrCam for its MyEye 2 assistive technology device for the blind and visually impaired. The OrCam MyEye 2 is a tiny, portable, artif
- Alnylam and Regeneron to Partner for RNAi Treatmentshttps://modernod.com/news/alnylam-regeneron-to-partner-for-rnai-treatments/2476457/Alnylam Pharmaceuticals and Regeneron Pharmaceuticals have agreed to jointly develop treatments for eye and central nervous system diseases using gene-silencing technology RNA interference (RNAi). Regeneron will make a $400 million upfront payment to Alnylam and also purchase $400 mill
- Allegro Ophthalmics Appoints Marc Carlson and Rebecca Colbert to Board of Directorshttps://modernod.com/news/allegro-ophthalmics-appoints-marc-carlson-and-rebecca-colbert-to-board-of-directors/2476454/Allegro Ophthalmics announced that two new independent members—Marc Carlson and Rebecca Colbert—have been appointed to the company’s Board of Directors with Ms. Colbert serving as Chairperson of the Board’s Audit Committee. Bringing extensive executive level commercial and financial leadership ex
- Nidek Launches the ARK-F/AR-F Auto Refractometerhttps://modernod.com/news/nidek-launches-the-ark-f-ar-f-auto-refractometer/2476446/Nidek has announced the launch of the ARK-F/AR-F Keratometer and Auto Refractometer. The ARK-F/AR-F features fully-automatic measurement. By placing the chin on the chinrest, the new Nidek eye detection camera
- A Soft Spot for Stem Cells Helps Cornea Healinghttps://modernod.com/news/a-soft-spot-for-stem-cells-helps-cornea-healing/2476436/New research led by scientists at Newcastle University, UK, reveals a potential revolutionary way to treat eye injuries and prevent blindness—by softening the tissue hosting the stem cells which then helps repair wounds inside the body. The team discovered that the simple application of a
- Ocutrx Vision Technologies Receives Second Patent for Augmented Reality Glasses Eye Tracking Technologyhttps://modernod.com/news/ocutrx-vision-technologies-receives-second-patent-for-augmented-reality-glasses-eye-tracking-technology/2476434/Ocutrx Vision Technologies, a manufacturer of augmented reality (AR) glasses, announced the issuance of the company’s second US patent, which will protect the company’s unique eye tracking technology for patients with macular degeneration and other low vision conditions. The patent applies to bot